Table 3.

Phenotypic reconstitution of mononuclear cell subsets 3 months and 12 months after transplantation

BMT, cells/μLPBSCT, cells/μLP
3 months after transplantation3-150    
 CD3+CD4+T cells 71.3 ± 49 182.2 ± 111 < .001 
 CD3+CD4+CD45RA+ T cells 11.2 ± 13.4 44.6 ± 41.0 < .002 
 CD3+CD4+CD45R0+ T cells 59.8 ± 43.7 124.3 ± 75.7 < .03 
 CD3+CD8+ T cells 274 ± 442 515 ± 563 NS  
 CD4/CD8 ratio 0.48 ± 0.8 0.66 ± 0.6 NS 
 CD19+ B cells 18.1 ± 86 20.4 ± 18 NS 
 Monocytes 483 ± 322 569 ± 286 NS 
 NK cells 164 ± 118 167 ± 131 NS  
12 months after transplantation3-151    
 CD3+CD4+T cells 191 ± 138 332 ± 188 < .01 
 CD3+CD4+CD45RA+ T cells 37.8 ± 42.4 85.6 ± 72.8 < .07 
 CD3+CD4+CD45R0+ T cells 181 ± 209 223 ± 116 NS 
 CD3+CD8+ T cells 500 ± 517 548 ± 425 NS  
 CD4/CD8 ratio 0.75 ± 0.8 0.82 ± 0.8 NS 
 CD19+ B cells 91.2 ± 119 87.2 ± 105 NS 
 Monocytes 475 ± 182 640 ± 436 NS 
 NK cells 137 ± 77 186 ± 132 < .03 
BMT, cells/μLPBSCT, cells/μLP
3 months after transplantation3-150    
 CD3+CD4+T cells 71.3 ± 49 182.2 ± 111 < .001 
 CD3+CD4+CD45RA+ T cells 11.2 ± 13.4 44.6 ± 41.0 < .002 
 CD3+CD4+CD45R0+ T cells 59.8 ± 43.7 124.3 ± 75.7 < .03 
 CD3+CD8+ T cells 274 ± 442 515 ± 563 NS  
 CD4/CD8 ratio 0.48 ± 0.8 0.66 ± 0.6 NS 
 CD19+ B cells 18.1 ± 86 20.4 ± 18 NS 
 Monocytes 483 ± 322 569 ± 286 NS 
 NK cells 164 ± 118 167 ± 131 NS  
12 months after transplantation3-151    
 CD3+CD4+T cells 191 ± 138 332 ± 188 < .01 
 CD3+CD4+CD45RA+ T cells 37.8 ± 42.4 85.6 ± 72.8 < .07 
 CD3+CD4+CD45R0+ T cells 181 ± 209 223 ± 116 NS 
 CD3+CD8+ T cells 500 ± 517 548 ± 425 NS  
 CD4/CD8 ratio 0.75 ± 0.8 0.82 ± 0.8 NS 
 CD19+ B cells 91.2 ± 119 87.2 ± 105 NS 
 Monocytes 475 ± 182 640 ± 436 NS 
 NK cells 137 ± 77 186 ± 132 < .03 

CD3+CD4+ T cells are T-helper cells; CD3+CD4+CD45RA+ T cells, naive T-helper cells; CD3+CD4+CD45R0+ T cells, memory T-helper cells.

NK cells indicate natural killer cells; for other abbreviations, see Table 1.

F3-150

Number of evaluated patients was 37 in the BMT group and 23 in the PBSCT group.

F3-151

Number of evaluated patients was 32 in the BMT group and 19 in the PBSCT group.

Close Modal

or Create an Account

Close Modal
Close Modal